Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Interest Coverage Ratio (2017 - 2022)

Sutro Biopharma's Interest Coverage Ratio history spans 6 years, with the latest figure at 7.61 for Q3 2022.

  • For Q3 2022, Interest Coverage Ratio rose 82.01% year-over-year to 7.61; the TTM value through Jun 2023 reached 56.98, down 19.22%, while the annual FY2021 figure was 31.41, 80.2% down from the prior year.
  • Interest Coverage Ratio for Q3 2022 was 7.61 at Sutro Biopharma, up from 32.62 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 23.84 in Q2 2018 and bottomed at 59.56 in Q1 2022.
  • The 5-year median for Interest Coverage Ratio is 12.3 (2019), against an average of 17.14.
  • The largest annual shift saw Interest Coverage Ratio soared 161.0% in 2020 before it crashed 822.81% in 2021.
  • A 5-year view of Interest Coverage Ratio shows it stood at 5.05 in 2018, then plummeted by 458.55% to 18.09 in 2019, then surged by 161.0% to 11.04 in 2020, then tumbled by 618.72% to 57.25 in 2021, then soared by 86.71% to 7.61 in 2022.
  • Per Business Quant, the three most recent readings for STRO's Interest Coverage Ratio are 7.61 (Q3 2022), 32.62 (Q2 2022), and 59.56 (Q1 2022).